Millipore Sigma Vibrant Logo

220285 Chelerythrine Chloride - CAS 3895-92-9 - Calbiochem

Naturally-occurring alkaloid.

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
Primary Target: PKC
View Products on Sigmaaldrich.com
220285
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
3895-92-9C₂₁H₁₈NO₄Cl

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
220285-5MG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Ampoule plast. 5 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewNaturally-occurring alkaloid. Potent, selective, and cell-permeable inhibitor of protein kinase C (IC50 = 660 nM). Acts on the catalytic domain of PKC. A competitive inhibitor with respect to the phosphate acceptor and a non-competitive inhibitor with respect to ATP. Over ten-fold more potent than H-7, HCl (Cat. No. 371955). Inhibits thromboxane formation and phosphoinositide metabolism in platelets. Also induces apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells.
      Catalogue Number220285
      Brand Family Calbiochem®
      References
      ReferencesKandasamy, R.A., et al. 1995. J. Biol. Chem. 270 29209.
      Jarvis, W.D., et al. 1994. Cancer Res. 54, 1707.
      Barg, J., et al. 1992. J. Neurochem. 59, 1145.
      Herbert, J.M., et al. 1990. Biochem. Biophys. Res. Commun. 172, 993.
      Ko, F., et al. 1990. Biochim. Biophys. Acta 1052, 360.
      Walterova, D., et al. J. Med. Chem. 24, 1100.
      Product Information
      CAS number3895-92-9
      ATP CompetitiveN
      FormLight yellow to yellow solid
      Hill FormulaC₂₁H₁₈NO₄Cl
      Chemical formulaC₂₁H₁₈NO₄Cl
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPKC
      Primary Target IC<sub>50</sub>660 nM
      Purity≥97% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSFL9200000
      Safety Information
      R PhraseR: 20/21/22-36/37/38

      Harmful by inhalation, in contact with skin and if swallowed.
      Irritating to eyes, respiratory system and skin.
      S PhraseS: 26-36

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      220285-5MG 07790788048761

      Documentation

      Required Licenses

      Title
      PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

      Chelerythrine Chloride - CAS 3895-92-9 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Chelerythrine Chloride - CAS 3895-92-9 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      220285

      Références bibliographiques

      Aperçu de la référence bibliographique
      Kandasamy, R.A., et al. 1995. J. Biol. Chem. 270 29209.
      Jarvis, W.D., et al. 1994. Cancer Res. 54, 1707.
      Barg, J., et al. 1992. J. Neurochem. 59, 1145.
      Herbert, J.M., et al. 1990. Biochem. Biophys. Res. Commun. 172, 993.
      Ko, F., et al. 1990. Biochim. Biophys. Acta 1052, 360.
      Walterova, D., et al. J. Med. Chem. 24, 1100.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision15-July-2022 JSW
      DescriptionNaturally occurring alkaloid. Cell-permeable, selective inhibitor of protein kinase C (IC50 = 660 nM). Acts on the catalytic domain irrespective of the attachment of the regulatory domain. Material is a competitive inhibitor with respect to the phosphate acceptor and a non-competitive inhibitor with respect to ATP. Over ten-fold more potent than H-7, HCl (Cat. No. 371955). Inhibits thromboxane formation and phosphoinositide metabolism in platelets. Also induces apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells.
      FormLight yellow to yellow solid
      CAS number3895-92-9
      RTECSFL9200000
      Chemical formulaC₂₁H₁₈NO₄Cl
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityDMSO (10 mg/ml) or H₂O (1 mg/ml). Heating to 40-50°C with gentle agitation may be necessary to achieve complete solubilization. Further dilute with buffer just prior to use.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
      Toxicity Harmful
      Merck USA index14, 2051
      ReferencesKandasamy, R.A., et al. 1995. J. Biol. Chem. 270 29209.
      Jarvis, W.D., et al. 1994. Cancer Res. 54, 1707.
      Barg, J., et al. 1992. J. Neurochem. 59, 1145.
      Herbert, J.M., et al. 1990. Biochem. Biophys. Res. Commun. 172, 993.
      Ko, F., et al. 1990. Biochim. Biophys. Acta 1052, 360.
      Walterova, D., et al. J. Med. Chem. 24, 1100.